A 3D Printed Assistive Technology Intervention
1 other identifier
interventional
14
0 countries
N/A
Brief Summary
The purpose of this study is to understand the feasibility of using a 3D printer to create tailored assistive technology rehabilitation devices. Specifically, we are investigating if a tailored 3D printed pillbox is safe, acceptable, and effective compared to an off-the-shelf generic pillbox. In this study, approximately 20 people with chronic health conditions who use pillboxes will describe their satisfaction and medication adherence with their current pillbox using a series of surveys and interviews. Then they will partake in an interview about their pillbox, medications, and routines. Based on the interview, the research team will 3D print a new pillbox tailored to the participant's preferences, abilities, and medication regimen. Then the participant will use the pillbox for 2-8 weeks. At the end, the participant will answer the same questions describing their satisfaction and medication adherence with the new pillbox using a series of surveys and interviews. This research will reveal important knowledge about the potential of 3D printing in the clinic and effectiveness of customized assistive technology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Jan 2017
Shorter than P25 for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedFirst Submitted
Initial submission to the registry
November 6, 2017
CompletedFirst Posted
Study publicly available on registry
November 24, 2017
CompletedNovember 24, 2017
November 1, 2017
4 months
November 6, 2017
November 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Incidence of Treatment-Emergent Adverse Events
The participant will be asked if they experienced any changes in their health or major issues using their pillbox at 1 week and at the end of the study. Also, all participants were educated to contact to the study team should they experience an adverse event.
1 week and again at 2-8 Weeks
Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST2.0)
The participant will complete the QUEST 2.0 to describe their satisfaction with the 3D printed pillbox as compared to their satisfaction with the off the shelf pillbox. This will demonstrate the acceptability of the device.
2-8 Weeks
Adherence to Refills and Medications Scale (ARMS)
Medication adherence as measured by the ARMS will demonstrate the preliminary efficacy of the of the 3D printed assistive technology. Specifically, it will help determine if the pillbox helped participants better take their medications as prescribed.
2-8 Weeks
Study Arms (1)
Off-The-Shelf Pillbox vs 3D Printed Pillbox
ACTIVE COMPARATORParticipants in the study were pillbox users at baseline. Participants described their experiences and preferences with their own pillbox. Then participants will be given a 3D printed pillbox. Researchers will compare participants' experiences and preferences between their off-the-shelf pillbox used at baseline and the customized 3D printed pillbox delivered to participants as part of the study.
Interventions
The research team interviewed the participant about their habits, routines, preferences, medications, and skills and abilities. Based on the interview, the research team designed and printed a customized 3D printed pillbox.
Eligibility Criteria
You may qualify if:
- English-speaking
- Adults (ages 18+ years)
- Use a pillbox at least weekly
- Prescribed 2+ medications
- Willing to try a new 3D printed pillbox
You may not qualify if:
- Have significant cognitive impairment evidenced by a score of 10+ on the short blessed test
- Unable to meet with the research team in person and by phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2017
First Posted
November 24, 2017
Study Start
January 1, 2017
Primary Completion
May 1, 2017
Study Completion
May 1, 2017
Last Updated
November 24, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share